Hikma Pharmaceutical | HIK - Pre Tax Profit



Hikma Pharmaceutical reported $144M in Pre-Tax Profit for its fiscal semester ending in June of 2024.


Pre Tax Profit Change Date
Almirall EUR 35.8M 37.9M Mar/2025
argenx SE USD 286.9M 84.54M Jun/2025
AstraZeneca USD 3.13B 275M Jun/2025
Autolus Therapeutics Ltd -47520000 20.42M Jun/2025
Bayer EUR -426000000 2.26B Jun/2025
Fresenius EUR 491M 120M Jun/2025
Galapagos EUR -156367000 175.4M Mar/2025
Genmab DKK 423M 179M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 144M 144M Jun/2024
Lonza CHF 624M 197M Dec/2024
Merck EUR 829M 127M Jun/2025
Orion EUR 103.4M 26.6M Jun/2025
Recordati EUR 119.49M 45.37M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025
UCB EUR 1.22B 781M Dec/2024